Literature DB >> 7826492

Seizures in Alzheimer's disease: clinicopathologic study.

M F Mendez1, P Catanzaro, R C Doss, R ARguello, W H Frey.   

Abstract

New-onset epileptic seizures occur in patients with Alzheimer's disease (AD), but the nature and underlying reasons for these seizures are unclear. We identified new-onset, nonsymptomatic seizures in 77 (17%) of 446 patients with uncomplicated, definite AD on autopsy. Among these seizure patients, 69 had generalized tonic-clonic seizures, and 55 had less than three total seizures. The seizure patients had a younger age of dementia onset than did the remaining AD patients; however, at seizure onset, they averaged 6.8 years into their AD and had advanced dementia. When further compared to 77 AD controls, matched for age of onset and duration, the seizure patients did not differ on medical illnesses, amount of medications, and degree of focal neuropathology. We conclude that a few unprovoked generalized seizures frequently occur late in the course of AD, and that AD patients with a younger age of dementia onset are particularly susceptible to seizures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826492     DOI: 10.1177/089198879400700407

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  42 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

Review 3.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

4.  Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Emily L Johnson; Gregory L Krauss; Keenan A Walker; Jason Brandt; Anna Kucharska-Newton; Thomas H Mosley; Sevil Yasar; Rebecca F Gottesman
Journal:  Epilepsia       Date:  2020-07-24       Impact factor: 5.864

5.  Seizures in Alzheimer disease: who, when, and how common?

Authors:  Nikolaos Scarmeas; Lawrence S Honig; Hyunmi Choi; Julio Cantero; Jason Brandt; Deborah Blacker; Marilyn Albert; Joan C Amatniek; Karen Marder; Karen Bell; W Allen Hauser; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-08

6.  Synaptic Adhesion Molecule Pcdh-γC5 Mediates Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Yanfang Li; Zhicai Chen; Yue Gao; Gaojie Pan; Honghua Zheng; Yunwu Zhang; Huaxi Xu; Guojun Bu; Hui Zheng
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

Review 7.  Epidemiology and drug treatment of epilepsy in elderly people.

Authors:  E Faught
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

8.  BACE1 regulates voltage-gated sodium channels and neuronal activity.

Authors:  Doo Yeon Kim; Bryce W Carey; Haibin Wang; Laura A M Ingano; Alexander M Binshtok; Mary H Wertz; Warren H Pettingell; Ping He; Virginia M-Y Lee; Clifford J Woolf; Dora M Kovacs
Journal:  Nat Cell Biol       Date:  2007-06-18       Impact factor: 28.824

9.  Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome.

Authors:  Satish C Rao; Gerald Dove; Gregory D Cascino; Ronald C Petersen
Journal:  Epilepsy Behav       Date:  2008-10-08       Impact factor: 2.937

10.  Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

Authors:  D M Wilcock; M P Vitek; C A Colton
Journal:  Neuroscience       Date:  2009-01-19       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.